Vimal Mehta - May 14, 2023 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
CEO and President
Signature
/s/ Richard Steinhart, as attorney-in-fact for Vimal Mehta
Stock symbol
BTAI
Transactions as of
May 14, 2023
Transactions value $
$0
Form type
4
Date filed
5/16/2023, 08:33 PM
Previous filing
Mar 22, 2023
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTAI Common Stock Options Exercise +15K +94.38% 30.9K May 14, 2023 Direct F1
holding BTAI Common Stock 2K May 14, 2023 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Restricted Stock Units Options Exercise $0 -15K -100% $0.00* 0 May 14, 2023 Common Stock 15K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 On May 14, 2022, the Reporting Person was granted 15,000 RSUs that vested and settled on May 14, 2023.

Remarks:

This Form 4 does not include 8,546,750 shares of common stock previously reported as indirectly owned by the Reporting Person because the Reporting Person is not presently considered the beneficial owner of such shares.